FDA
-
-
-
-
-
-
-
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
-
-
-
-
-
-
-
Mainz Biomed receives UK regulatory approval for ColoAlert cancer test
-
-
-
-
-
-
-
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
-
-
-
-
-
-
-
Mainz Biomed Enters into Technology Partnership with EDX Medical Group
-
-
-
-
-
-
-
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
-
-
-
-
-
-
-
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
-
-
-
-
-
-
-
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

